Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

MALLINCKRODT PLC

(MNKKQ)
  Rapport
Cours en différé. Temps Différé Nyse - 29/11 22:00:02
0.176 USD   -4.86%
22/02DBV TECHNOLOGIES : nouvelle directrice juridique
CF
2020Mallinckrodt se déclare en faillite pour régler des plaintes
AW
2020La Vieille Europe bouge encore
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur MALLINCKRODT PLC
23/11NORTH AMERICAN MORNING BRIEFING : Stock Futures Slip, Yields Rise After Powell's Fed Nomin..
23/11EMEA MORNING BRIEFING : Stocks to Track Wall -2-
05/11Kathy Schaefer Issues Resignation from Mallinckrodt plc as Senior Vice President of Fin..
05/11Regulation FD Disclosure - Form 8-K
03/11Mallinckrodt plc Announces Executive Changes
02/11Net Debt Leverage Q3 2021 11-02-2021
02/11Non-GAAP Definitions Q3 2021 11-02-2021
02/11Third Quarter Financial Results - Form 8-K
02/11NORTH AMERICAN MORNING BRIEFING : Stock Futures Steady After Wall Street Records
01/11ANI Pharma Shares Take Flight as FDA Approves Return of Cortrophin Gel
01/11ANI Pharmaceuticals Gets FDA OK to Bring Back Cortrophin Gel
28/10Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations i..
26/10SUBJECT TO FRE 408, STATE LAW EQUIVA : Refresh of 2021 Strategic Plan September 2021 - For..
25/10Mallinckrodt plc Presents Results on Real World Treatment Patterns and Outcomes in Hosp..
15/10PRO BANKRUPTCY BRIEFING : J&J Unit Files Bankruptcy Over Talc Claims; Purdue Appeals to Be..
05/10U.S. Supreme Court rejects challenge to New York tax on opioid companies
04/10U.S. Supreme Court rejects challenge to New York tax on opioid companies
03/09Mallinckrodt Reaches Settlement Agreement With More Creditors
02/09MALLINCKRODT : Presents Interim Results on Real World Use of Extracorporeal Photopheresis ..
31/08ANI PHARMACEUTICALS : FDA Accepts Application for Cortrophin Gel Revival
13/08Mallinckrodt Provides Information to the Shareholders
05/08Buxton Helmsley Sends Letter to Mallinckrodt plc
03/08MALLINCKRODT : Non-GAAP Definitions Q2 2021 08-03-2021
03/08MALLINCKRODT : Net Debt Leverage Q2 2021 08-03-2021
03/08MALLINCKRODT : Second Quarter Financial Results (Form 8-K)
03/08TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
03/08Mallinckrodt plc Reports Earnings Results for the Second Quarter Ended June 25, 2021
03/08Buxton Helmsley Provides Information to the Shareholders
22/07ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties, cities fo..
22/07U.S. state officials urge support for landmark $26 billion opioid settlement
21/07Drugmakers, pharmacies next targets for U.S. opioid settlements
20/07MARKET CHATTER : Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes Settlemen..
20/07U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sourc..
07/07Mallinckrodt plc Announces Publication of Phase 3 STRATA2016 Study in Burns
02/07MALLINCKRODT : Announces Inclusion of Acthar Gel (Repository Corticotropin Injection) in N..
01/07MALLINCKRODT : Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in ..
01/07Mallinckrodt plc Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection..
30/06AMBRX BIOPHARMA : Names Sonja Nelson Finance Chief
24/06MALLINCKRODT PLC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibi..
16/06Mallinckrodt Announces U.S. FDA Approval of StrataGraft®
15/06Second Amended Joint Reorganization Plan and Further Revised Disclosure Statement Filed..
14/06MALLINCKRODT PLC : Regulation FD Disclosure (form 8-K)
08/06First Amended Joint Reorganization Plan and Revised Disclosure Statement Filed by Malli..
19/05Motion for Asset Sale Filed by Mallinckrodt plc
04/05MALLINCKRODT : Presents Data Evaluating Acthar Gel (Repository Corticotropin Injection) fo..
04/05MALLINCKRODT : 2020 Irish Statutory Accounts
04/05MALLINCKRODT : First Quarter Financial Results
04/05MALLINCKRODT : Non-GAAP Definitions Q1 2021 05-04-2021
04/05MALLINCKRODT : Net Debt Leverage Q1 2021 05-04-2021
04/05MALLINCKRODT : Management's Discussion and Analysis of Financial Condition and Results of ..
04/05TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
04/05Mallinckrodt plc Reports Earnings Results for the First Quarter Ended March 26, 2021
03/05MALLINCKRODT : Presents Data Evaluating INOmax (Nitric Oxide) Gas, for Inhalation in a Pha..
03/05MALLINCKRODT : Presents Data Evaluating Acthar® Gel (Repository Corticotropin Injection) f..
03/05Mallinckrodt Presents Data Evaluating Acthar Gel for the Treatment of Severe Keratitis ..
02/05MALLINCKRODT : Acthar Gel Phase 4 Keratitis ARVO Poster
30/04MALLINCKRODT : Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Ph..
30/04Mallinckrodt plc Presents Data Evaluating Inomax® (Nitric Oxide) Gas, for Inhalation in..
28/04Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Coll..
20/04Joint Reorganization Plan and Disclosure Statement Filed by Mallinckrodt plc
30/03Silence Therapeutics Posts Bigger FY20 Loss On Higher Expenses
24/03MALLINCKRODT : Supports Healthcare Businesswomen's Association as Two Employees Honored wi..
22/03MALLINCKRODT : Announces U.S. Food and Drug Administration (FDA) Approves Updated Acthar® ..
18/03MALLINCKRODT : Announces 2021 Advancing Extracorporeal Photopheresis Immunomodulation Inve..
10/03Buxton Helmsley Sends Letter to Mallinckrodt plc
10/03TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..
10/03MALLINCKRODT : Non-GAAP Definitions Q4 2020 03-10-2021
10/03MALLINCKRODT : Net Debt Leverage Q4 2020 03-10-2021
10/03Mallinckrodt plc Auditor Raises 'Going Concern' Doubt
08/03MALLINCKRODT : Initial Insider Trading Report (SEC Filing - 3)
04/03Mallinckrodt Announces New England Journal of Medicine Publication of Results from its ..
26/02Silence Therapeutics plc & Mallinckrodt plc Initiate Work on 3Rd Target
25/02First Motion for Exclusivity Period Extension Approved For Mallinckrodt plc
12/02Mallinckrodt Provides Regulatory Update on StrataGraft®
10/02MALLINCKRODT : Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur MALLINCKRODT PLC